ClinicalTrials.gg
RecruitingNCT05926973VOCALISTUpdated Jul 3, 2023

VectOr ChAnge defibriLlatIon in Refractory Shockable rhyThms

An observational study in Cardiac Arrest, Ventricular Fibrillation and Ventricular Tachycardia, sponsored by Thames Valley Air Ambulance. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-03.

Sponsored by Thames Valley Air Ambulance · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2023, 3 years 4 months ago, but the record still lists the study as recruiting.
  • Started May 2023; still recruiting 3 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 40 studies in Heart Arrest with a site in United Kingdom — 4 open to participants now, 6 under way, none of them phase 3. Heart Arrest · United Kingdom.

Planned enrollment
15th of 21
50 · median 200
Started
2023
with 1 other
Observational
21 of 40
3 open now
Registered
35th of 40
by date

Among the 40 studies in Heart Arrest with a site in United Kingdom, this one is the 15th largest by planned enrollment of the 21 observational ones that give a count, is one of 2 that started in 2023, is one of 21 observational ones, and was the 35th registered.

Heart Arrest

927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

Browse Heart Arrest studies →

Open to participants now

4 of the 40 studies in Heart Arrest with a site in United Kingdom are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 40 studies in Heart Arrest with a site in United Kingdom, or all of them as a file.
02

Study summary

Management of cardiac arrest according to published guidelines has remained largely unchanged for a decade. Thames Valley Air Ambulance provide Critical Care Paramedic and Physician teams who respond to cardiac arrests and offer treatments beyond the scope of ambulance service clinicians. Following a review of practice and appraisal of evidence the investigators developed an additional algorithm for cases of adult medical cardiac arrest with refractory shockable rhythms. This adds to but does not replace the Advanced Life Support algorithm and includes:

  • Delivering shocks with the LUCAS mechanical CPR device running
  • After 5 shocks have been delivered placing new pads in the Anterior Posterior (AP) position
  • Delivering shocks using the TVAA Tempus Pro defibrillator rather than the Ambulance Service defibrillator.

This bundle was based on recommendations from ILCOR and the Resus Council (UK) Advanced Life Support manual and was launched in October 2021.

Read the detailed description

Study hypothesis An enhanced algorithm for refractory shockable rhythms terminates VF/VT and improves outcomes (ROSC at hospital) in out of hospital cardiac arrest.

Study design

PICOST Population - adult patients with medical cardiac arrest in refractory shockable rhythms (defined as continuous VF or VT after 5 shocks).

Intervention - application of the TVAA enhanced cardiac arrest bundle Comparison - 18 month period before the introduction of the bundle (if the COVID period has significantly different response times than the intervention group then the COVID period will be excluded).

Outcome - primary outcome measure is ROSC at hospital (as this represents the success of the pre-hospital phase of resuscitation).

Study design - Retrospective observational study using the TVAA HEMSBASE database Timeframe - 18 months of data since the bundle was introduced.

Exclusions - traumatic cardiac arrests, cardiac arrests where the VF/VT was recurrent (could be terminated but then restarted) rather than refractory (unable to get the patient out of the shockable rhythm). Refractory VF refers to VF that persists despite shock delivery (i.e. shock-resistant VF). This is distinguished from recurrent VF, which is VF that re-appears after it has been terminated (2). In this study refractory would be defined as continuous VF or VT after 5 shocks.

Data set to be collected All data is held within HEMSBASE Age, sex, witnessed arrest, bystander CPR, time from 999 call to TVAA on scene, first rhythm, number of shocks (total in before group; number of shocks pre and post vector change in the after group), outcome (ROSC at any stage; PLE, died on arrival to ED, ROSC in ED).

Statistical analysis Statistical support will be sought from the South Central Research Design Service https://www.rds-sc.nihr.ac.uk Fisher's test or Chi square tests may be appropriate.

Ethical approval The HRA decision tools indicate that the study does not require REC review.

Search strategy Two independent researchers will search HEMSBASE for the intervention period (Oct 21 to April 23) and the control period (19 months prior to Oct 21, excluding the COVID period if response times are significantly different in this period) using the following strategy.

HEMSBASE search

  • Cardiac arrests
  • Initial rhythm VF or VT
  • Manual search looking for refractory shockable rhythms (defined as continuous VF or VT after 5 shocks with no change to ROSC or a non shockable rhythm at any stage).

This search strategy will deliver a list of cases of refractory shockable rhythms that can then be compared between the two reviewers to ensure all cases are included, any cases where there is not agreement will be adjudicated by a third reviewer. The cases will then be analysed for the data set above and entered into an excel spreadsheet.

Data security No patient identifiable data will be exported outside of HEMSBASE.

03

Conditions studied

  • Cardiac Arrest
  • Ventricular Fibrillation
  • Ventricular Tachycardia

Keywords

  • cardiac arrest
  • Refractory shockable rhythm
  • defibrillation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adult patients with medical cardiac arrest attended by TVAA, in refractory shockable rhythms (defined as continuous VF or VT after 5 shocks).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult patients with medical cardiac arrest
  • in shockable rhythms (defined as continuous VF or VT after 5 shocks).

Exclusion criteria

Exclusion Criteria:

  • traumatic cardiac arrests
  • cardiac arrests where the VF/VT was recurrent (could be terminated but then restarted) rather than (unable to get the patient out of the shockable rhythm). Refractory VF refers to VF that persists despite shock delivery (i.e. shock-resistant VF). This is distinguished from recurrent VF, which is VF that re-appears after it has been terminated (2). In this study refractory would be defined as continuous VF or VT after 5 shocks.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Relapsed and refractory

Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Before intervention

    Standard care as per ALS guidelines prior to October 2021

  • After intervention

    Enhanced cardiac arrest management as per TVAA guideline from October 2021 onwards

    Other: Enhanced cardiac arrest bundle

Interventions

  • OtherEnhanced cardiac arrest bundle

    * Delivering shocks with the LUCAS mechanical CPR device running * After 5 shocks have been delivered placing new pads in the Anterior Posterior (AP) position * Delivering shocks using the TVAA Tempus Pro defibrillator rather than the Ambulance Service defibrillator.

    Also known as: Vector change defibrillation

06

What researchers measure

Primary outcomes

  1. ROSC at hospital

    ROSC at hospital

    Time frame: within 24 hours of arrest

Secondary outcomes

  1. PLE rate

    PLE - death declared at scene

    Time frame: within 24 hours of arrest

Other outcomes

  1. Total defibrillation shocks

    Total defibrillation shocks

    Time frame: within 24 hours of arrest

07

Study locations

1 of 1 sites recruiting
  • Thames Valley Air Ambulance
    Oxford, Oxfordshire, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — No individual patient data to be shared

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2023 (actual). Primary completion is estimated for Jun 2023, 1 month after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2023
First posted
Jul 3, 2023
StartActual
May 1, 2023
Primary completionEst.
Jun 30, 2023
CompletionEst.
Sep 2023
Last update
Jul 3, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05926973
Lead sponsor
Thames Valley Air Ambulance
Responsible party
James Raitt (Audit, Improvement and Research Lead, Thames Valley Air Ambulance) — Principal investigator
First posted
Jul 3, 2023
Start date
May 1, 2023
Primary completion
Jun 30, 2023 (estimated)
Completion
Sep 2023 (estimated)
Last update
Jul 3, 2023

Study contacts

James Raitt, MBChB
Contact
james.raitt@tvairambulance.org.uk
0300 999 0135

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion